Clinical Trials

17 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung

NCT00064012 2019-12-13

Bortezomib With or Without Docetaxel in Treating Patients With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer

4 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00798720 2019-12-13

Vorinostat and Bortezomib as Third-line Treatment in Advanced Non-small Cell Lung Cancer

18 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung

NCT00714246 2019-06-24

Bortezomib (PS-341) in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer

Phase 1 Terminated

6 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00424840 2019-02-01

Phase I/II Study to Evaluate the Efficacy and Safety of a Combination Chemotherapy

Phase 1 Terminated

12 enrolled 2 charts

Lung Neoplasms

NCT00389805 2018-10-31

Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors

Phase 1/2 Completed

27 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00200382 2018-08-02

Phase II Study of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung Cancer

27 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00458913 2018-07-12

Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma

82 enrolled

Mesothelioma, Malignant

NCT00093756 2017-12-07

Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer

Phase 1/2 Completed

52 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

NCT00362882 2017-12-05

Docetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer

81 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

NCT00622674 2017-12-02

Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors

BreastGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

37 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms, Small Cell Lung Carcinoma

NCT00620295 2017-11-29

Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors

BreastGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

17 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Osteosarcoma, Uterine Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma

NCT00731952 2017-05-04

Phase I Study of Induction Therapy With VELCADE and Vorinostat in Patients With Surgically Resectable Non-Small Cell Lung Cancer

21 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00580320 2016-08-18

Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma

DermatologicEndocrineHead & NeckSarcomaThoracic

17 enrolled

Carcinoid Tumor, Melanoma, Parathyroid Neoplasms, Sarcoma, Small Cell Lung Carcinoma

NCT01633645 2015-09-28

Bortezomib in Combination With Gemcitabine and Cisplatin in Advanced or Metastatic Non-Small Cell Lung Cancer

53 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT00513877 2014-12-31

Bortezomib in Treating Patients With Malignant Pleural Mesothelioma

33 enrolled

Mesothelioma, Malignant

NCT00118144 2014-08-21

Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer

42 enrolled 7 charts

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung

NCT00313690 2014-05-21

Cancer Treatment Followed by Surgery for Early Stage Non-small Cell Lung Cancer

Phase 1/2 Withdrawn

Lung Neoplasms

NCT00068289 2013-06-24

Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

Lung Neoplasms, Small Cell Lung Carcinoma

NCT00118183 2013-06-04

Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

62 enrolled

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant

NCT00075751 2013-02-28

Gemcitabine, Carboplatin, and Bortezomib in Advanced or Recurrent Non-Small Cell Lung Cancer

99 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00346645 2013-02-06

A Phase II Study of Velcade® in Patients Stage IIIB OR IV Non-Small Cell Lung Cancer

46 enrolled

STAGE IIIB OR IV NON-SMALL CELL LUNG CANCER

NCT00052338 2013-01-23

Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

34 enrolled

Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant

NCT00040768 2013-01-16

Bortezomib in Treating Patients With Advanced Non-small Cell Lung Cancer

35 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00411593 2012-02-08

Phase I-II for Patients With Recurrent or Refractory Non-small Cell Lung Cancer (NSCLC)

Phase 1/2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00996385 2011-10-31

Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma

Phase 2 Unknown

29 enrolled

Mesothelioma, Malignant, Mesothelioma

NCT00667641 2011-05-10

Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

BreastDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

16 enrolled

Carcinoma, Ovarian Epithelial, Thyroid Cancer, Papillary, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms

NCT00117351 2011-02-17

VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features

Adenocarcinoma, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung

NCT00283634 2011-02-17

A Study of Tarceva for Use in Patients With Relapsed or Refractory Metastatic Non-Small Cell Lung Cancer

NSCLC

NCT00388089 2010-06-29

Bortezomib and Topotecan in Treating Patients With Advanced Solid Tumors

24 enrolled

Lung Neoplasms, Small Cell Lung Carcinoma

NCT00516100 2010-01-15

Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC

Phase 1/2 Unknown

62 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00343720 2008-03-13

Study of Alimta® (Pemetrexed) Plus VELCADE® (Bortezomib) or Alimta Alone or VELCADE Alone in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior Therapy

Pathologic Complete Response, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT00051974 2008-02-11

Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

155 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00064636 2005-06-24

Phase I Dose Escalation Study of VELCADE Plus Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors

Phase 1 Terminated

46 enrolled